Krystal Biotech Inc
$1.6M 1,118 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Integrity Implants Inc. dba Accelus
Integrity Implants Inc. dba Accelus reported $1,586,902.08 across General Payments, Research, and Ownership to 1,045 physicians and teaching hospitals across 1,045 transactions.
- $1.6M Above-median payer
- All-tracks total
- 1,045 Above-median volume
- Transactions
- 1,045 Above-median reach
- Recipients
- +$121.1K
- General Payments vs PY2023
Integrity Implants Inc. dba Accelus reported $1,586,902.08 across all CMS Open Payments tracks (General + Research + Ownership) to 1,045 physicians and teaching hospitals in Program Year 2024 - ranking #512 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,586,902.08, averaging $1.5K per recipient.
Integrity Implants Inc. dba Accelus's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
28/100
Total payments
F
25/100
Transaction volume
F
18/100
Physician reach
F
18/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer integrity-implants-inc-dba-accelus Integrity Implants Inc. dba Accelus
$1.6M · #512/1,925 · 0.0% industry · PY2024
- TOT $1.6M
- RANK #512
- SHARE 0.0%
- TXN 1,045
- RCP 1,045
- CAT 4
- GEN $1.6M
- ΔGEN +$121.1K
- TOP1 8.8%
- PY 2024
Volume peers
Nearest volume peer: Krystal Biotech Inc ($1.6M)
Integrity Implants Inc. dba Accelus sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Integrity Implants Inc. dba Accelus's CMS-reported General Payments increased by $121.1K (+8.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: INTEGRITY IMPLANTS INC. DBA ACCELUSPY2024: Integrity Implants Inc. dba Accelus. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,465,787.34
- PY2024
- $1,586,902.08
What the Data Shows for Integrity Implants Inc. dba Accelus
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Integrity Implants Inc. dba Accelus that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
237 transactions worth $1.2M make "Royalty or License" the top general-payment category in the 4-category breakdown below, 78.6% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Integrity Implants Inc. dba Accelus made 4 types of general payments. "Royalty or License" is the largest category at $1.2M, 78.6% of General Payments.
Integrity Implants Inc. dba Accelus reports 4 general-payment categories - the top three are Royalty or License (78.6%), Consulting Fee (13.4%), and Travel and Lodging (5.3%). The remaining 1 category make up 2.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Integrity Implants Inc. dba Accelus divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $1.2M | 237 | 78.6% |
| Consulting Fee | $213.4K | 67 | 13.4% |
| Travel and Lodging | $84.2K | 250 | 5.3% |
| Food and Beverage | $42.1K | 491 | 2.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $537,738.94 (33.9%) of $1,586,902.08 in this company's General Payments records across 196 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Integrity Implants Inc. dba Accelus
The five named recipients with the highest reported General Payments from this company
- 1
Rohit Vasan
$138,925.63 across 22 reported transactions
- 2
Paul Houle
$134,792.60 across 86 reported transactions
- 3
Alan McGee
$92,336.86 across 10 reported transactions
- 4
Domagoj Coric
$91,643.31 across 8 reported transactions
- 5
Robert Norton
$80,040.54 across 24 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Integrity Implants Inc. dba Accelus ranks #512 of 1,925 by total payments (top 27% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,366 of 1,838 by HHI (bottom 26% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Boehringer Ingelheim International GmbH : $4.5M total payments, HHI 421
- Music City Medical Technologies, LLC : $11.8K total payments, HHI 420
- Reel Surgical, Inc. : $22.5K total payments, HHI 417
- Brainsway USA INC : $36.9K total payments, HHI 416
- Erbe USA Inc : $161.0K total payments, HHI 415
- OsteoCentric Technologies, Inc. : $303.4K total payments, HHI 412
- Integrity Implants Inc. dba Accelus (this company) : $1.6M total payments, HHI 412
- Provepharm Inc. : $41.4K total payments, HHI 411
- TriSalus Life Sciences, Inc. : $443.3K total payments, HHI 411
- Tarsus Pharmaceuticals, Inc. : $5.3M total payments, HHI 409
- Roche Diagnostics Corporation : $552.8K total payments, HHI 407
- PROCEPT BioRobotics Corporation : $1.7M total payments, HHI 405
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Integrity Implants Inc. dba Accelus's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Integrity Implants Inc. dba Accelus.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Integrity Implants Inc. dba Accelus.
Showing 6 of 1,924 companies with CMS-reported payment data.
Veloxis Pharmaceuticals, Inc.
$1.6M 766 recipients
Compare payment profiles
Valneva Austria GMBH
$1.6M 1 recipients
Compare payment profiles
Datascope Corp.
$1.6M 14 recipients
Compare payment profiles
restor3d, inc.
$1.6M 1,071 recipients
Compare payment profiles
Ethicon US, LLC
$1.6M 15,448 recipients
Compare payment profiles
Put this to use
Integrity Implants Inc. dba Accelus ranks #512 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where Integrity Implants Inc. dba Accelus sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Integrity Implants Inc. dba Accelus. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.